 <h1>Targretin Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>bexarotene</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about bexarotene. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Targretin.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bexarotene: oral capsule, oral capsule liquid filled</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule)</p><p>Bexarotene capsules are a member of the retinoid class of drugs that is associated with birth defects in humans. Bexarotene capsules also caused birth defects when administered orally to pregnant rats. Bexarotene capsules must not be administered to a pregnant woman.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bexarotene (the active ingredient contained in Targretin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Since this medication is given in varying doses, the actual frequency of side effects may vary. In general, side effects are less common with lower doses than with higher doses.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking bexarotene:</p><p>
<i>More common</i>
</p><ul>
<li>Unusual tiredness or weakness</li>
<li>skin rash or other skin and mucous membrane lesions</li>
<li> fever</li>
<li>increase in lipid or cholesterol levels</li>
<li>coldness, dry, puffy skin or weight gain</li>
<li> chills, cough, hoarseness, lower back or side pain or painful or difficult urination</li>
<li>swelling of the arms, feet, hands, or legs</li>
</ul><p>
<i>Less Common</i>
</p><ul>
<li>Severe stomach pain with nausea or vomiting</li>
<li> shortness of breath</li>
<li>yellow eyes or skin </li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bexarotene may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal pain</li>
<li>hair loss</li>
<li>loss of appetite</li>
<li>loss of strength or energy, tiredness or weakness</li>
<li>back pain</li>
<li>diarrhea</li>
<li>dry skin</li>
<li> general feeling of discomfort or illness</li>
<li> trouble in sleeping</li>
<li>headache</li>
<li> nausea or vomiting </li>
</ul><p>
<!-- end oral capsule, oral capsule liquid filled --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bexarotene: oral capsule</i></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased HDL cholesterol (up to 90%), hyperlipemia (up to 79%), elevated cholesterol (up to 75%), elevated triglycerides (up to 70%), hypercholesterolemia (up to 62%), hypocholesterolemia (up to 28%), anorexia (up to 23%), increased lactic dehydrogenase (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Weight gain, hypoproteinemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Gout</p>
<p><b>Frequency not reported</b>: Elevated LDL cholesterol, decreased weight, dehydration, increased alkaline phosphatase, hypercalcemia, hypocalcemia, hypernatremia, hyponatremia, hyperkalemia, hypokalemia, hypolipemia, hypomagnesemia, increased appetite, thirst, hypovolemia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Decreased TSH (up to 60%), hypothyroidism (up to 53%), decreased total T4 (up to 45%)</p>
<p><b>Common</b> (1% to 10%): Thyroid disorder, altered hormone level</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperthyroidism</p>
<p><b>Frequency not reported</b>: Hyperglycemia, decreased libido, increased and decreased gonadotropic luteinizing hormone<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Leukopenia (up to 47%), anemia (up to 25%), hypochromic anemia (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Lymphoma-like reaction, lymphadenopathy</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood dyscrasia, coagulation disorder, increased coagulation time, thrombocytopenia, thrombocythemia, eosinophilia, leukocytosis, lymphocytosis, abnormal erythrocytes</p>
<p><b>Frequency not reported</b>: Neutropenia, decreased thromboplastin, bone marrow suppression, decreased absolute neutrophil count, decreased absolute lymphocyte count, decrease white blood cell count, decreased hemoglobin<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (up to 45%), infection (up to 23%), fever (up to 17%), bacterial infection (up to 13%), chills (up to 13%), flu syndrome (up to 13%), peripheral edema (up to 13%), pain (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Deafness</p>
<p><b>Uncommon</b> (0.1% to 1%): Ear disorder, parasitic infection, edema, mucous membrane disorder, abnormal lab test</p>
<p><b>Frequency not reported</b>: Chest pain, breast pain, breast enlargement, sepsis, ear pain, otitis externa, tinnitus, malaise, viral infection<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 42%), nausea (up to 16%), vomiting (up to 13%), abdominal pain (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Cheilitis, constipation, dry mouth, flatulence</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, gastrointestinal disorder</p>
<p><b>Frequency not reported</b>: Colitis, melena, dyspepsia, gastroenteritis, gingivitis, increased amylase, increased lipase, stomatitis, abnormal stools, tenesmus, pelvic pain, eructation, enlarged abdomen, dysphagia, mouth ulceration, oral moniliasis, gingivitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 42%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, hypesthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Ataxia, neuropathy, vertigo, hyperesthesia</p>
<p><b>Frequency not reported</b>: Syncope, cerebrovascular accident, subdural hematoma, migraine, peripheral neuritis, paresthesia, somnolence, stupor, circumoral paresthesia, taste perversion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Exfoliative dermatitis (up to 28%), rash (up to 23%), pruritus (up to 20%), dry skin (up to 17%), alopecia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Skin ulcer, skin hypertrophy, skin nodule, acne, sweating, skin disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Purpura, serous drainage, herpes simplex, pustular rash, cellulitis, skin discoloration, hair disorder, nail disorder</p>
<p><b>Frequency not reported</b>: Maculopapular rash, vesicular bullous rash, ecchymosis, petechia, pallor, psoriasis, furunculosis, contact dermatitis, herpes zoster, seborrhea, lichenoid dermatitis, photosensitivity reaction, face edema, body odor<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Cataracts/lens opacities (up to 19%)</p>
<p><b>Common</b> (1% to 10%): Dry eyes, eye disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Amblyopia, visual field defect, corneal lesion, abnormal vision, blepharitis, conjunctivitis</p>
<p><b>Frequency not reported</b>: Keratitis, night blindness, nystagmus, lacrimation disorder, eye pain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Arthralgia, myalgia, bone pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Myasthenia</p>
<p><b>Frequency not reported</b>: Arthrosis, increased creatinine phosphokinase, hypertonia, leg cramps, abnormal gait, arthritis, joint disorder<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 11%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Depression, agitation</p>
<p><b>Frequency not reported</b>: Anxiety, emotional lability, abnormal thinking, confusion, nervousness<sup>[Ref]</sup></p><h3>General</h3><p>Due to its primarily retinoid X receptor (RXR)-binding activity, this drug is less likely to cause adverse effects (arthralgia; myalgia; and mucocutaneous, nail, and hair toxicities) frequently reported with retinoic acid receptor (RAR)-binding agents.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased SGPT/ALT, increased SGOT/AST, increased bilirubin</p>
<p><b>Uncommon</b> (0.1% to 1%): Bilirubinemia, liver failure</p>
<p><b>Frequency not reported</b>: Cholestasis, cholecystitis, liver damage, jaundice<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Allergic reaction<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Increased creatinine</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased BUN, abnormal kidney function<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, hemorrhage, hypertension, vasodilation, varicose vein</p>
<p><b>Frequency not reported</b>: Angina pectoris, right heart failure, arrhythmia, peripheral vascular disorder, decreased prothrombin, congestive heart failure, palpitation, vascular anomaly, vascular disorder<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Albuminuria</p>
<p><b>Frequency not reported</b>: Hematuria, urinary incontinence, urinary tract infection, urinary urgency, dysuria, monilia infection, hyperuricemia, urinary retention, impaired urination, polyuria, nocturia, urine abnormality<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Neoplasm</p>
<p><b>Frequency not reported</b>: Carcinoma<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Pharyngitis, rhinitis, dyspnea, pleural effusion, bronchitis, increased cough, lung edema, hemoptysis, hypoxia, pneumonia, sinusitis, epistaxis, respiratory disorder, lung disorder, pleural disorder, laryngismus<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Targretin (bexarotene)" Ligand Pharmaceuticals, San Diego, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Targretin (bexarotene)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Targretin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Targretin topical</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Cutaneous T-cell Lymphoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bexarotene: oral capsule</i></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased HDL cholesterol (up to 90%), hyperlipemia (up to 79%), elevated cholesterol (up to 75%), elevated triglycerides (up to 70%), hypercholesterolemia (up to 62%), hypocholesterolemia (up to 28%), anorexia (up to 23%), increased lactic dehydrogenase (up to 13%)</p><p><b>Common</b> (1% to 10%): Weight gain, hypoproteinemia</p><p><b>Uncommon</b> (0.1% to 1%): Gout</p><p><b>Frequency not reported</b>: Elevated LDL cholesterol, decreased weight, dehydration, increased alkaline phosphatase, hypercalcemia, hypocalcemia, hypernatremia, hyponatremia, hyperkalemia, hypokalemia, hypolipemia, hypomagnesemia, increased appetite, thirst, hypovolemia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Decreased TSH (up to 60%), hypothyroidism (up to 53%), decreased total T4 (up to 45%)</p><p><b>Common</b> (1% to 10%): Thyroid disorder, altered hormone level</p><p><b>Uncommon</b> (0.1% to 1%): Hyperthyroidism</p><p><b>Frequency not reported</b>: Hyperglycemia, decreased libido, increased and decreased gonadotropic luteinizing hormone<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Leukopenia (up to 47%), anemia (up to 25%), hypochromic anemia (up to 13%)</p><p><b>Common</b> (1% to 10%): Lymphoma-like reaction, lymphadenopathy</p><p><b>Uncommon</b> (0.1% to 1%): Blood dyscrasia, coagulation disorder, increased coagulation time, thrombocytopenia, thrombocythemia, eosinophilia, leukocytosis, lymphocytosis, abnormal erythrocytes</p><p><b>Frequency not reported</b>: Neutropenia, decreased thromboplastin, bone marrow suppression, decreased absolute neutrophil count, decreased absolute lymphocyte count, decrease white blood cell count, decreased hemoglobin<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (up to 45%), infection (up to 23%), fever (up to 17%), bacterial infection (up to 13%), chills (up to 13%), flu syndrome (up to 13%), peripheral edema (up to 13%), pain (up to 12%)</p><p><b>Common</b> (1% to 10%): Deafness</p><p><b>Uncommon</b> (0.1% to 1%): Ear disorder, parasitic infection, edema, mucous membrane disorder, abnormal lab test</p><p><b>Frequency not reported</b>: Chest pain, breast pain, breast enlargement, sepsis, ear pain, otitis externa, tinnitus, malaise, viral infection<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 42%), nausea (up to 16%), vomiting (up to 13%), abdominal pain (up to 11%)</p><p><b>Common</b> (1% to 10%): Cheilitis, constipation, dry mouth, flatulence</p><p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, gastrointestinal disorder</p><p><b>Frequency not reported</b>: Colitis, melena, dyspepsia, gastroenteritis, gingivitis, increased amylase, increased lipase, stomatitis, abnormal stools, tenesmus, pelvic pain, eructation, enlarged abdomen, dysphagia, mouth ulceration, oral moniliasis, gingivitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 42%)</p><p><b>Common</b> (1% to 10%): Dizziness, hypesthesia</p><p><b>Uncommon</b> (0.1% to 1%): Ataxia, neuropathy, vertigo, hyperesthesia</p><p><b>Frequency not reported</b>: Syncope, cerebrovascular accident, subdural hematoma, migraine, peripheral neuritis, paresthesia, somnolence, stupor, circumoral paresthesia, taste perversion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Exfoliative dermatitis (up to 28%), rash (up to 23%), pruritus (up to 20%), dry skin (up to 17%), alopecia (up to 11%)</p><p><b>Common</b> (1% to 10%): Skin ulcer, skin hypertrophy, skin nodule, acne, sweating, skin disorder</p><p><b>Uncommon</b> (0.1% to 1%): Purpura, serous drainage, herpes simplex, pustular rash, cellulitis, skin discoloration, hair disorder, nail disorder</p><p><b>Frequency not reported</b>: Maculopapular rash, vesicular bullous rash, ecchymosis, petechia, pallor, psoriasis, furunculosis, contact dermatitis, herpes zoster, seborrhea, lichenoid dermatitis, photosensitivity reaction, face edema, body odor<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Cataracts/lens opacities (up to 19%)</p><p><b>Common</b> (1% to 10%): Dry eyes, eye disorder</p><p><b>Uncommon</b> (0.1% to 1%): Amblyopia, visual field defect, corneal lesion, abnormal vision, blepharitis, conjunctivitis</p><p><b>Frequency not reported</b>: Keratitis, night blindness, nystagmus, lacrimation disorder, eye pain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 11%)</p><p><b>Common</b> (1% to 10%): Arthralgia, myalgia, bone pain</p><p><b>Uncommon</b> (0.1% to 1%): Myasthenia</p><p><b>Frequency not reported</b>: Arthrosis, increased creatinine phosphokinase, hypertonia, leg cramps, abnormal gait, arthritis, joint disorder<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 11%)</p><p><b>Uncommon</b> (0.1% to 1%): Depression, agitation</p><p><b>Frequency not reported</b>: Anxiety, emotional lability, abnormal thinking, confusion, nervousness<sup>[Ref]</sup></p><h3>General</h3><p>Due to its primarily retinoid X receptor (RXR)-binding activity, this drug is less likely to cause adverse effects (arthralgia; myalgia; and mucocutaneous, nail, and hair toxicities) frequently reported with retinoic acid receptor (RAR)-binding agents.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased SGPT/ALT, increased SGOT/AST, increased bilirubin</p><p><b>Uncommon</b> (0.1% to 1%): Bilirubinemia, liver failure</p><p><b>Frequency not reported</b>: Cholestasis, cholecystitis, liver damage, jaundice<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Allergic reaction<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Increased creatinine</p><p><b>Uncommon</b> (0.1% to 1%): Increased BUN, abnormal kidney function<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, hemorrhage, hypertension, vasodilation, varicose vein</p><p><b>Frequency not reported</b>: Angina pectoris, right heart failure, arrhythmia, peripheral vascular disorder, decreased prothrombin, congestive heart failure, palpitation, vascular anomaly, vascular disorder<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Albuminuria</p><p><b>Frequency not reported</b>: Hematuria, urinary incontinence, urinary tract infection, urinary urgency, dysuria, monilia infection, hyperuricemia, urinary retention, impaired urination, polyuria, nocturia, urine abnormality<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Neoplasm</p><p><b>Frequency not reported</b>: Carcinoma<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Pharyngitis, rhinitis, dyspnea, pleural effusion, bronchitis, increased cough, lung edema, hemoptysis, hypoxia, pneumonia, sinusitis, epistaxis, respiratory disorder, lung disorder, pleural disorder, laryngismus<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Targretin (bexarotene)" Ligand Pharmaceuticals, San Diego, CA. </p><h2>More about Targretin (bexarotene)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Targretin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Targretin topical</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cutaneous T-cell Lymphoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>